Abstract
Introduction
The accumulation of amyloidogenic proteins is a common feature observed in different human diseases, such as Alzheimer's disease, Prion diseases, Parkinson's disease, and type 2 diabetes [1] . In the past decades, studies have demonstrated that the amyloidogenic proteins can trigger cytotoxicities through interacting with neuronal membranes and affecting their normal structures and functions. For example, the amyloid proteins/ peptides have been proven to change membrane fluidity [2, 3] , induce the abnormal channel formation [4] [5] [6] [7] , produce free radicals and cause the lipid peroxidation [8, 9] . As the typical fatal neurodegenerative disorders, Prion diseases are characterized by the cerebral amyloid accumulation of an abnormally misfolded, protease-resistant, and β-sheet rich pathogenic isoform PrP Sc (scrapie PrP), which is derived from the normal cellsurface glycoprotein PrP c (cellular PrP)] [10] . Current studies have revealed that the hydrophobic domain (residues 111-134) of PrP, as a type II signal-anchor sequence, can direct the translocation of the C-terminus of PrP across the membrane to produce the pathogenic Ctm PrP (C-terminus transmembrane PrP), which spans the lipid bilayer of the endoplasmic reticulum membrane with its C-terminus located on the membraneextrinsic side [11, 12] . However, little is known about how the amyloidogenic PrP protein perturbs lipid membranes.
PrP106-126 (K 106 TNMKHMAGAAAAGAVVGGLG 126 , numbered according to the human PrP sequence) is a highly conserved segment located in the unstructured N-terminal region and adjacent to the well-ordered globular domain of PrP. It plays an important role in the conformational conversion and aggregation of PrP [13] . Because of the difficulties in isolating and characterizing PrP Sc , it is generally acceptable to use PrP106-126 as a substitute of PrP Sc to study the physicochemical and pathological properties of PrP [14] . As an alternative, PrP106-126 peptide possesses many properties of PrP Sc , including the partial protease resistance, the propensity to adopt β-sheet conformation and form amyloid fibrils, as well as the ability to induce the nerve cell degeneration in a number of different primary cell cultures [15] [16] [17] [18] . The primary structure of PrP106-126 is characterized by two distinct regions, a hydrophilic region (K 106 TNMKHM 112 ) and a hydrophobic region (A 113 GAAAA-GAVVGGLG 126 ), which render a favorable condition for interacting with cell membranes [4] [5] [6] 15, 19] . Interestingly, both the amyloidogenicity and the neurotoxicity of PrP106-126 are very sensitive to minor molecular modifications, such as oxidation, chemically conformational stabilization, structural relaxation and C-terminal amidation [20, 21] . Although it is still controversial whether PrP106-126 amide could cause the PrP cdependent neurotoxicity [20] [21] [22] , the slow kinetics of the fibrogenesis of PrP106-126 amide in physiological conditions [23] makes it an ideal model for studying its properties on the lipid membranes by in situ time-lapse atomic force microscopy (AFM).
In this work, we focused on the studies of PrP106-126 amide interacting with the mica-supported lipid bilayers (SLBs) under aqueous conditions by in situ time-lapse AFM. SLB is a broadly applied model system for the investigation of membrane-related processes, e.g. cell adhesion [24] , drugmembrane interactions [25] and protein-membrane interactions [26] [27] [28] [29] [30] [31] [32] [33] . Our results demonstrate that PrP106-126 amide induced the distinctive semi-penetrated poration in the SLBs; subsequently, the flat high-rise domains (FHDs) were formed due to the diffusion of the peptide into the hydrophobic regions of the lipid bilayers. It provides a new insight into the process of PrP106-126 interacting with lipid membranes. The possible mechanisms of PrP106-126 amide interacting with lipid bilayers are proposed based on our results.
Materials and methods

Chemicals
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC), cholesterol (Chl) and 1,6-diphenyl-1,3,5-hexatrine (DPH) were purchased from SigmaAldrich (USA). 1-aminonaphthalene-3,6,8-trisulfonic acid (ANTS) and N,N′-pxylylenebis (pyridinium) bromide (DPX) were purchased from Molecular Probes (USA). Three different buffers were used for sample preparation and AFM imaging: PBS (20 mM Na 2 HPO 4 , 5 mM NaH 2 PO 4 , 125 mM NaCl, 5 mM KCl, pH 7.4); HBS1 (50 mM HEPES, 100 mM NaCl, 2 mM CaCl 2 , pH 7.4); and HBS2 (50 mM HEPES, 100 mM NaCl, pH 7.4). All the buffers were filtered through 0.2 μm filters prior to use. Ultrapure water (18 MΩ) was used for the buffer preparations and the experiments. 
Peptide preparation
LUVs preparation
The lipid was dissolved in chloroform/methanol (2:1, v/v) and dried in a rotary evaporator and then kept under high vacuum overnight. Multilamellar vesicles (MLVs) were prepared by adding 400 μl of the buffer into the bottle to hydrate the lipid at a concentration of 1.0 mg/ml, and then the solution was vortexed vigorously until it became constantly milky. LUVs were prepared by extrusion of the MLVs through a 0.1 μm polycarbonate membrane (Avanti Polar Lipids) at 65°C [29, 35] .
Fluorescence polarization measurements
The 1,6-diphenyl-1,3,5-hexatriene (DPH) solution in tetrahydrofuran (2.6 × 10 − 4 mol/L) was added into the LUVs solution in PBS at a molar ratio of 1:100 (probe: lipid), then the mixed solution was incubated at 25°C for 30 min in dark. PrP106-126 amide solution was added to the DPH-labeled LUVs at the final concentrations of 10 μM, 20 μM, 30 μM, 40 μM, and 50 μM, respectively. The mixed solution was immediately incubated at 25°C for 10 min in dark and then the fluorescence polarization was measured. The measurements were carried out on an F-4500 fluorescence spectrometer equipped with the polarization accessories (Hitachi, Japan). The data were collected at 25°C with the excitation wavelength at 360 nm and the emission wavelength at 430 nm. Both excitation and emission slits were set at 5 nm. The degree of fluorescence polarization (P), which reflects the motion and viscosity of lipid molecules, was calculated according to the following formula [36] : P = (I VV − GI VH ) / (I VV + GI VH ), where I VV and I VH are the fluorescence intensities measured with parallel and perpendicular oriented polarizers, respectively, and G is the calibration factor. Here, G = I HV / I HH , V =0, H = 0.
Permeability assay of the lipid vesicles
The LUVs were prepared as described in a mixed solution of 12.5 mM ANTS, 45 mM DPX, 50 mM HEPES (pH 7.4) and 20 mM NaCl. The vesicles were added onto a HiTrap™ desalting column and eluted with HBS2 to remove the unencapsulated ANTS and DPX and then diluted to a concentration lower than 100 μM. After 20 min of the PrP106-126 amide treatment, the fluorescence intensities were recorded at 25°C with the excitation wavelength at 355 nm and the emission wavelength at 512 nm (F-4500 fluorescence spectrometer, Hitachi, Japan). The fluorescence intensity corresponding to 100% leakage was determined by adding Triton X-100 (2.5%, v/v) into the vesicles until the maximum intensity achieved.
2.6. Preparation of SLBs 2.6.1. Preparation of SLBs in PBS [29, 35, 37] The LUVs solution was prepared as described by using PBS as the hydrating solution. SLBs were prepared by the vesicle fusion method [37] . Briefly, 80 μl of the LUVs suspension was pipetted on the freshly cleaved mica (8 mm in diameter) and incubated at 70°C for 2 h in a water bath. The sample was slowly cooled down to room temperature and then carefully rinsed with PBS to remove the excessive LUVs and the loosely adsorbed bilayers. The mounted bilayers were maintained in an aqueous environment. According to our measurements, the prepared SLBs can be stable in PBS for several days at room temperature. [27, 38] Through the same procedure described in the above section, SLBs in HBS were prepared by using HBS1 as the hydrating solution, and the mica covered by the SLB was rinsed by HBS2.
Preparation of SLBs in HBS
POPC bilayers are in the liquid crystalline state at room temperature, and the packing density is about 0.64 nm 2 per lipid molecule [39] . So that the amount of lipids on the mica surface (8 mm in diameter) is about 0.33 nmol if the prepared SLBs didn't have any defect. Since the total volume of buffer used for the AFM experiments is 100 μl, thus the lipid concentration on the mica surface is about 3.3 μM. Given that cholesterol packs into the acyl chains of the lipid bilayers as a molecular spacer, the lipid concentration of the POPC/Chl SLBs should be similar to that of the POPC SLBs.
Atomic force microscopy
AFM images of the solution-tapping mode were obtained on a multimode atomic force microscope with a Nanoscope IV controller (Veeco Instruments, USA) equipped with an EV-scanner. The sharpened OTR8 cantilevers (Veeco Instruments) with a nominal spring constant at 0.15 N/m were used for the AFM imaging. The frequency of the cantilever oscillation was tuned to 7-10 kHz and the drive amplitude was adjusted to get the RMS value between 1.0 and 2.0 V. The scan rate was set at 1.49 Hz. For the in situ time-lapse AFM experiments, SLBs were first imaged with the solution-tapping mode to check the initial states of SLBs before the PrP106-126 amide treatment. Then the PrP106-126 amide solution was injected into the sample to make a final concentration of 25 μM and the sample was scanned immediately at room temperature. During the experiment, 20 μL of the buffer was injected into the imaging field every 2 h to make up the evaporated liquid. All images were taken as 512 × 512 pixel scans and were flattened and plane-fitted by the Nanoscope Ш software (Ver. 5.12r2, Veeco Instruments) before the data analysis. The height and depth were measured by the "section" function and the percentage of FHDs area was analyzed by the "bearing" function of the Nanoscope Ш software. The percentage of the FHDs area was corrected by subtracting the area of pores. The FHDs expansion as a function of time was calculated using the following logistic function: y = a/[1 + b*exp(−c*x)], in which y is the percentage of FHDs area at the time of x min. Given the biological meanings of the functions (y is zero at 0 min and the maximal percentage of FHDs area is 100%), we name a = 100 and b ≥ 100 in this work.
Results
Membrane fluidity and permeability
In order to determine the effect of PrP106-126 amide on the membrane fluidity, we performed fluorescence polarization measurements using DPH as the probe. DPH can insert into the hydrophobic region of the membrane and is widely used to measure the order of the fatty acyl chains of the lipid bilayer. The relative motion of the DPH molecules within the lipid bilayer is determined by the polarization value P, which is inversely proportional to the degree of the membrane fluidity. As shown in Fig. 1 , after 10 min of incubation with PrP106-126 amide at 25°C, the fluidities of both POPC and POPC/Chl LUVs decreased with the peptide concentrations increasing. It suggests that PrP106-126 amide may insert into the hydrophobic regions of the lipid bilayers, therefore the motions of the fatty acyl chains are restricted. Notably, the absolute fluidity of POPC/Chl LUVs is always lower than that of POPC LUVs at the same peptide concentrations. It is reasonable that cholesterol molecules may insert into the intermolecular space of the POPC lipids thus increase the packing density of the acyl chains of the lipids and decrease the fluidity of the membrane [40] [41] [42] [43] .
To further assess the membrane perturbation induced by PrP106-126 amide, the ANTS-DPX leakage experiments were performed for both POPC and POPC/Chl LUVs based on the fact that the fluorescence of ANTS can be quenched by DPX within very short distances. The results show that the peptideinduced leakage of POPC LUVs is greater than that of POPC/ Chl LUVs at the same peptide concentrations (Fig. 2) . Typically, for POPC LUVs, we observed 25% of leakage at a peptide concentration of 100 μM, whereas the same amount of peptide gave rise to only 6% of the leakage of POPC/Chl LUVs. It is consistent with the fluidity assay and could be ascribed to the role of cholesterol in stabilizing lipid assemblies [40] [41] [42] 44 ].
AFM imaging of peptide-SLBs interactions
In situ time-lapse AFM experiments were carried out to visualize the structural and morphological features of the mica based SLBs in the presence of PrP106-126 amide. Two SLBs model systems, POPC and POPC/Chl (4:1, mol/mol), were investigated in two different buffers (PBS and HBS), respectively. The averaged height of the SLBs is about 5 nm observed by AFM (data not shown) and consistent with the data of other groups [37, 45] . 
POPC and POPC/Chl SLBs in PBS
In Fig. 3 , a set of in situ time-lapse images of the POPC SLB interacting with PrP106-126 amide in 25 mM PBS was presented. The SLB was first imaged to check the initial state without the presence of the peptide (Fig. 3 at 0 min) . After injection of PrP106-126 amide, FHDs appeared on the SLB at the sixth minute, which are higher than the surrounding lipid bilayer (Fig. 3 at 6 min) . They expanded in size laterally and fused together gradually with the time prolonging, and took up nearly 100% of the visual field at 60 min. The height difference between the FHDs and the surrounding lipid bilayer is about 1.6 ± 0.3 nm (n = 11) [Fig. 3, section analysis (1) ]. Strikingly, there is a pore located in the middle of almost each formed FHDs. The deepest depth of the pores on FHDs is about 4.4 nm [Fig. 3, section analysis (2) ]. Consequently, the relative depth of the pore to the top surface of the SLB is only about 2.8 ± 0.3 nm (Fig. 8) . Since the heights of POPC bilayer and the FHDs are about 5 nm and 6.6 ± 0.3 nm, respectively, thus the pores probably penetrate through one leaflet of the bilayer. The formed FHDs and pores were stable in the aqueous solution for at least 1290 min (Fig. 3 at 1290 min) , implying that the formations of pores and FHDs are the dominant phenomena of the peptide interacting with the SLB. In addition, we captured two spots in the visual field (Fig. 3 , indicated by black arrows), which were presented on the top of the SLB surface prior to the peptide treatment and remained at the same positions with the same sizes throughout the experiment. Without the treatment of the peptide, we didn't observe the FHDs and pores on the SLB (data not shown). Taken together, we presume that the pores may be associated with PrP106-126 amide inserting into the membrane and the FHDs expansion is observed due to the diffusion of PrP106-126 amide in the SLB. Fig. 4 presents the PrP106-126 amide interacting with POPC/Chl (4:1, mol/mol) SLB in PBS solution. The SLB poration and the FHDs formation and expansion were also observed (Fig. 4) . It seems that the pores were formed before the FHD formation (Fig. 4b and b′) . Interestingly, an original porelike structural "defect" on the SLB was observed before adding PrP106-126 amide (Fig. 4a) , and an FHD was formed round it at the sixth minute upon the treatment of the peptide (Fig. 4a′) . Although it was rare to capture such a structural defect on SLBs, this result, at least, implicates that the structural defect of membranes could be a native starting point in mediating PrP106-126 amide diffusion into SLBs. Similar to the pores observed in the POPC SLB, the relative depth of the deepest pore to the top surface of the POPC/Chl SLB is about 3.0 ± 0.1 nm (Figs. 4 and 8 ).
POPC and POPC/Chl SLBs in HBS
Due to the limitation of the scanning speed for AFM to image a visual field, it was difficult to track the initial process of the SLBs poration induced by PrP106-126 amide. However, in the experiments, we found that HEPES buffer efficiently decelerated the diffusion of the peptide in SLBs. It may be because the zwitterionic HEPES molecules competitively prohibit the electrostatic adsorption of PrP106-126 amide onto the zwitterionic surface of lipid membranes. In HBS, we were able to record the slower dynamics of the SLBs poration induced by PrP106-126 amide.
As shown in Fig. 5 , the pores were observed at 18 min after adding the peptide. The formed FHDs are about 2.5 ± 0.1 nm (n = 11) higher than the surrounding lipid bilayer [ (2)], thus the relative depth of the pore to the top surface of the POPC SLB is about 2.7 ± 0.1 nm (Fig. 8) , similar to the pores observed in PBS solution. A pore-forming region was zoomed in and shown as the inset in the 18-min picture (Fig. 5 ). There were some small sized FHDs located near the pores, which grew up and fused into larger FHDs as shown in the frame of the 24-min picture (Fig.  5) . The similar phenomena have also been observed in the experiment for the POPC/Chl SLB in PBS (Fig. 4b and b′) . Fig. 6 shows the PrP106-126 amide diffused into the POPC/Chl (4:1, mol/mol) SLB in HBS. Pores appeared at 24 min and subsequently turned to be surrounded by the small sized FHDs at 30 min ( Fig. 6a and a′) . The FHDs expanded and fused together and took up the whole SLB area after 60 min of the peptide treatment, whereas the pores remained at the same positions (Fig. 6) . The depth of the deepest pore is about 3.1 ± 0.2 nm (Figs. 6 and 8) . Notably, we found that the small sized FHDs could be formed in the field without a pore (Fig. 6b) , which also expanded with the time prolonging. But the expansion rate of such FHDs is much slower than that of the pore-mediated FHDs (Fig. 6b and b′). Although this phenomenon was rare during the experiments, it implies that the FHDs formation is possible without the SLBs poration. In turn, they may promote the poration (Fig. 6b, b′ and b′′) . We assume this phenomenon could be associated with a special mode of the insertion of PrP106-126 amide into SLBs.
Interestingly, in both HBS and PBS buffers, the number of pores formed in POPC/Chl SLBs is much more than that in POPC SLBs (Figs. 5 and 6) . Also, the expansion rate of FHDs in POPC/Chl SLBs is quicker than that in POPC SLBs (Fig. 7) .
Discussion
By combination of fluorescence polarization measurement, dye release assay and in situ time-lapse AFM, we were able to investigate the actions of PrP106-126 amide on the model membranes. The results demonstrate that PrP106-126 amide perturbs SLBs predominately through a poration-mediated process. Similar phenomena have also been reported by the studies of some antimicrobial peptides interacting with lipid membranes [46] .
Semi-penetrated pores formation
Currently, there are three proposed models about peptideinduced poration in lipid bilayers: carpet model, barrel-stave model, and toroidal model for α-helical antimicrobial peptides [46] [47] [48] [49] . In any case, the poration starts with the peptide adsorption to the membrane surface that leads to a lateral expansion of the membrane and a thinning of the hydrophobic lipid core [50, 51] . In order to reduce the strains imposed on the bilayers by the peptides, the membrane systems with different physicochemical characteristics will respond in different ways.
By in situ time-lapse AFM, we directly observed the porations induced by PrP106-126 amide in the different SLBs (Figs. 3-6) . However, the pores formed could not penetrate through the membranes and the deepest depth of the pores is only about half of the thickness of the lipid bilayer. So they are different from any of the current poration models [46] [47] [48] [49] , in which the peptide induced pores can penetrate through the lipid bilayers. The depths of the pores resulted from PrP106-126 amide in the different SLBs are summarized in Fig. 8 , revealing the higher depths of pores are related to the thicker membranes caused by the cholesterol packing into the acyl chains of the lipids.
As an amphiphilic peptide, PrP106-126 amide has the potential to associate with POPC bilayers and form peptidelipid complexes. To reduce the membrane strains caused by the peptide association, the peptide-lipid complexes may be forced to retreat gradually, leaving the pores in the SLBs [50, 51] . The exposed hydrophobic pores could be stabilized by binding the amphiphilic peptides (Fig. 9) . Furthermore, since the pores are position-steady throughout the AFM imaging (Figs. 3-6) , it is reasonable to assume that the FHDs expansion is predominantly resulted from the semi-penetrated porations in the SLBs. Once the pores are formed, the FHDs can expand quickly (Figs. 4-7) .
Our experiments suggest the semi-penetrated poration could be a new mode of peptide-membrane interactions, which mediated the PrP106-126 amide diffusion into the lipid bilayers. This distinct feature is highly consistent with the phenomena of the decrease of the membrane fluidity but the slightly increase of the membrane permeability caused by PrP106-126 amide ( Figs. 1 and 2 ).
Cholesterol and HEPES effects
The formation and expansion of FHDs induced by PrP106-126 amide were studied in different membrane systems and summarized in Fig. 7 . In both PBS and HBS buffers, cholesterol significantly accelerates the growing dynamics of FHDs in the SLBs. We found that, in a visual field of the same size, there were more pores formed in POPC/Chl SLBs than in POPC SLBs under the same conditions (Figs. 3-6) . Also, PrP106-126 amide diffused much quicker in POPC/Chl SLBs than in POPC SLBs as shown in Fig. 7 . By retarding the dynamics of PrP106-126 amide diffusion into POPC/Chl SLBs with HEPES, we were able to observe that the overall diffusion process resembles a typical "S" shaped curve with the amount of FHDs remained at a almost unvaried low level within the first 25 min (Fig. 7) . Comparably, AFM imaging indicates that only a few pores formed in this time period (Fig. 6) . Together, these phenomena further strengthen our hypothesis that the semi-penetrated poration could mediate PrP106-126 amide diffusion into the lipid bilayers.
It seemed HEPES mainly affected the initial stage of the peptide diffusion (Fig. 7) . As a zwitterionic molecule, HEPES potentially interacts with the zwitterionic surface of the POPC membrane and thus inhibits the adsorption of the cationic peptide onto the SLB membrane by providing a cushion layer. Therefore, HEPES may affect the dynamics of the PrP106-126 amide diffusion by retarding the peptide to get a threshold concentration for the poration in the SLB membrane.
In the POPC/Chl SLB buffered by HBS, a large number of pores were formed in a time period following the initial lag phase, termed "mid-phase" in Fig. 7 . In the mid-phase, the FHDs expanded quickly till they filled up the visual fields. Whereas in the SLBs without cholesterol, in the mid-phase, there were fewer pores formed and the rates of FHDs expansion were also slower. It implies that cholesterol may favor the poration of the SLB thereby affects the dynamics of the peptide diffusion.
After the treatment of PrP106-126 amide, the membrane fluidities of POPC/Chl and POPC LUVs changed in a parallel as well as linear fashion (Fig. 1) , implicating that cholesterol may stabilize the lipid assemblies by packing into the region of lipid acyl chains as a spacer to increase the membrane density [40] [41] [42] , but may not provide additional thermodynamic contributions for the peptide-membrane interactions. However, cholesterol can also promote the phase transition and microdomains formation [40] [41] [42] , which, we assume, could downregulate the threshold concentration of the peptide required for the SLB poration. Therefore, under the same conditions, there were more pores formed in the SLBs containing cholesterol (Figs. 3-6 ).
The possible mechanisms
To our knowledge, no other research reported the semipenetrated poration in SLBs induced by peptides. Based on our experiments and the above analysis, we propose three possible poration models to illustrate the possible mechanisms of PrP106-126 amide interacting with SLBs (Fig. 9) . In model A, the cationic as well as hydrophilic N-terminus of PrP106-126 amide is adsorbed on the zwitterionic surface of the POPC membrane at first, then the hydrophobic C-terminus would form hydrophobic clusters in the membrane. This process may favor the formation of the peptide-lipid complexes on the upper leaflet of the SLB and increase the membrane strain. When a desired threshold concentration of the peptide reaches, the membrane could be relaxed through releasing the vesicles of the peptide-lipid complex and leaving the pores in the membrane. Subsequently, more amphiphilic peptides bind the exposed lipids and stabilize the pores and at the same time quickly diffuse into the lipid bilayer through the pores. It results in the phase transition represented by the formation and expansion of FHDs. In model B, the amphiphilic peptide can also insert directly into the zwitterionic membrane at a specific orientation, in which the peptide-lipid complexes cannot be released. As a consequence, only small sized FHDs appear and grow slowly. While nearby, the packing of the lipids could be disturbed so as to adapt the phase transition and later on, the peptide-lipid complex vesicles are formed and released. Subsequently, more and more of the peptide molecules diffuse into the lipid bilayer through the pores. Model C shows the poration is originated from the defects on the membrane, which could be occurred during the bilayers preparation or AFM imaging, but they are rarely observed in the experiments.
Although our experiments were performed on the simple lipid bilayers, we were able to observe the distinct patterns of the retarded peptide-membrane interactions by using the Camidated PrP106-126. It implicates that the neurotoxicity of the pathogenic PrP Sc in real cells could be related to the specific membrane disturbance to a certain extent. Given the phenomena of the semi-penetrated poration and the FHDs expansion, the integrity and functions of cell membranes could be severely disrupted, and some membrane proteins could also be affected in a way. Further studies to address the exact locations of the peptide by fluorescence microscopy would help to unveil the detailed molecular basis of the membrane perturbation of PrP106-126. On the other hand, investigations of the changes of the lipid structure/phase and the microdomains on membranes may provide more information on the peptidemembrane interactions.
Investigating peptide-lipid interaction by in situ time-lapse AFM
In situ time-lapse AFM is a powerful tool for studying biomolecules interacting with SLBs [26, 52, 53] . Generally, AFM has the following advantages of imaging the interactions of macromolecules: (1) the processes of biological interactions can be visualized under the physiological conditions; (2) it has a high spacial resolution (in sub-nanometer range); (3) interactions can be monitored in time-lapse experiments; (4) unlike other techniques, samples can be viewed in their native states without complicate preparations and chemical modifications. However, the poor temporal resolution (in minute range) greatly limits the AFM applications. To overcome such limitation, zwitterionic agents such as HEPES may be used in experiments to retard some biological interactions. Notably, confocal-atomic force microscopy, which has high temporal and spatial resolutions, is being exploited successfully in tracking the peptide-membrane interactions [50, 54] .
